Literature DB >> 9294922

A short history and introductory background on the coxsackieviruses of group B.

R L Crowell1, B J Landau.   

Abstract

The past 50 years have revealed an array of significant developments in our documentation and understanding of viruses and their associated diseases. The CVB, as enteroviruses, were discovered in the search for poliomyelitis-related viruses by the inoculation of newborn mice. Future strategies for the discovery of additional viruses will undoubtedly come through the application of differentiating cell culture systems with increased susceptibility to infection by specific viruses. Developments in regulation of the cell cycle also will contribute to the better definition of events controlling persistent infections caused by the CVB. Methods utilizing molecular biological probes in situ will prove to be major aids in identifying the molecular events in CVB pathogenesis. Virology of the CVB continues to be an exciting area for research and application of preventive measures to lesson human suffering. The chapters in this book which follow will amplify most of the themes briefly presented here.

Entities:  

Mesh:

Year:  1997        PMID: 9294922     DOI: 10.1007/978-3-642-60687-8_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  8 in total

1.  Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon.

Authors:  David V Serreze; Clive Wasserfall; Eric W Ottendorfer; Michael Stalvey; Melissa A Pierce; Charles Gauntt; Brian O'Donnell; James B Flanagan; Martha Campbell-Thompson; Tamir M Ellis; Mark A Atkinson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Acute and chronic disease caused by enteroviruses.

Authors:  Julian W Tang; Christopher W Holmes
Journal:  Virulence       Date:  2017-03-31       Impact factor: 5.882

3.  The nonstructural protein 2C of Coxsackie B virus has RNA helicase and chaperoning activities.

Authors:  Ziyu Chen; Xiaobei Xiong; Yiyang Li; Muhan Huang; Yujie Ren; Di Wu; Yang Qiu; Mingzhou Chen; Ting Shu; Xi Zhou
Journal:  Virol Sin       Date:  2022-05-16       Impact factor: 6.947

4.  Altered interactions between stem-loop IV within the 5' noncoding region of coxsackievirus RNA and poly(rC) binding protein 2: effects on IRES-mediated translation and viral infectivity.

Authors:  Polen Sean; Joseph H C Nguyen; Bert L Semler
Journal:  Virology       Date:  2009-05-14       Impact factor: 3.616

Review 5.  Enterovirus and parechovirus infection in children: a brief overview.

Authors:  S C M de Crom; J W A Rossen; A M van Furth; C C Obihara
Journal:  Eur J Pediatr       Date:  2016-05-07       Impact factor: 3.183

6.  In vitro and in vivo studies of the inhibitory effects of emodin isolated from Polygonum cuspidatum on Coxsakievirus B₄.

Authors:  Zhao Liu; Fei Wei; Liang-Jun Chen; Hai-Rong Xiong; Yuan-Yuan Liu; Fan Luo; Wei Hou; Hong Xiao; Zhan-Qiu Yang
Journal:  Molecules       Date:  2013-09-25       Impact factor: 4.411

7.  Coxsackievirus B4: an underestimated pathogen associated with a hand, foot, and mouth disease outbreak.

Authors:  Jinbo Xiao; Jianxing Wang; Yong Zhang; Xianjun Wang; Dapeng Sun; Huanhuan Lu; Zhenzhi Han; Yang Song; Dongmei Yan; Shuangli Zhu; Yaowen Pei; Wenbo Xu
Journal:  Arch Virol       Date:  2021-06-06       Impact factor: 2.685

8.  Molecular docking study and antiviral evaluation of 2-thioxo-benzo[g]quinazolin-4(3H)-one derivatives.

Authors:  Rashad Al-Salahi; Hatem A Abuelizz; Hazem A Ghabbour; Rabab El-Dib; Mohamed Marzouk
Journal:  Chem Cent J       Date:  2016-04-19       Impact factor: 4.215

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.